Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Research and development spending
3Y CAGR
-8.6%/yr
vs +38.5%/yr prior
5Y CAGR
-0.3%/yr
Recent deceleration
Acceleration
-47.1pp
Decelerating
Percentile
P58
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
4 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $295.85M | -9.7% |
| 2024 | $327.57M | -7.6% |
| 2023 | $354.39M | -8.5% |
| 2022 | $387.24M | -8.0% |
| 2021 | $420.87M | +40.3% |
| 2020 | $299.92M | +35.7% |
| 2019 | $220.97M | +109.9% |
| 2018 | $105.29M | +161.2% |
| 2017 | $40.30M | +75.4% |
| 2016 | $22.98M | - |